Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jan 14, 2008; 14(2): 255-259
Published online Jan 14, 2008. doi: 10.3748/wjg.14.255
Published online Jan 14, 2008. doi: 10.3748/wjg.14.255
Table 2 Virological response rates
| Group A (n = 22) | Group-B (n = 14) | P | |
| Early response | |||
| Virological (%) | 82.4 | 0 | < 0.001 |
| End-of-treatment response | |||
| Virological (%) | 82.4 | 0 | < 0.001 |
| Sustained response | |||
| Virological (%) | 64.7 | 0 | < 0.001 |
- Citation: Ayaz C, Celen MK, Yuce UN, Geyik MF. Efficacy and safety of pegylated-interferon α-2a in hemodialysis patients with chronic hepatitis C. World J Gastroenterol 2008; 14(2): 255-259
- URL: https://www.wjgnet.com/1007-9327/full/v14/i2/255.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.255